Arthritis Research & Therapy

Volume 16 Supplement 1

Lupus 2014: New Targets, New Approaches

Meeting abstracts

Edited by John Esdaile, Paul R Fortin, Matthew Liang, Peter Lipsky and Daniel Wallace

Publication charges for this supplement were funded by the conference.

Lupus 2014: New Targets, New Approaches.

Quebec City, Canada18-20 September 2014

Page 2 of 2

A comprehensive approach to identify approved drugs and treatments for repositioning as therapies for systemic lupus erythematosus

Authors: Amrie C Grammer, Matthew Ryals and Peter E Lipsky

Citation: Arthritis Research & Therapy 2014 16(Suppl 1):A51

Content type: Meeting abstract Published on: 18 September 2014
- View Full Text
- View PDF
Cluster analysis of longitudinal treatment patterns in patients newly diagnosed with systemic lupus erythematosus in the United States

Authors: Hong Kan, Saurabh Nagar, Jeetvan Patel, Daniel J Wallace and Charles Molta

Citation: Arthritis Research & Therapy 2014 16(Suppl 1):A52

Content type: Meeting abstract Published on: 18 September 2014
- View Full Text
- View PDF
Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial

Authors: David Isenberg, Yong Li, Stephen Wax, David Wofsy and Caroline Gordon

Citation: Arthritis Research & Therapy 2014 16(Suppl 1):A53

Content type: Meeting abstract Published on: 18 September 2014
- View Full Text
- View PDF

Previous page
1
2
Next page

Submit manuscript

Follow

Annual Journal Metrics

Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518

Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 111

Usage 2023
Downloads: 3,331,819
Altmetric mentions: 1,885
More about our metrics

ISSN: 1478-6362

Contact us

General enquiries: journalsubmissions@springernature.com